InsidersTradesSigma
화일약품 Stock: price and insider trades · South Korea · DART (FSS)
Track the 화일약품 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 화일약품 has published 64 public disclosures. Market capitalisation: €71.3bn. The latest transaction was disclosed on 2 July 2026 (Other). Among the most active insiders: CG인바이츠. Every trade is accessible without an account.
64
Insider Decl.
0
Thresholds
€2,733
12 ops.
Buy Volume
€159m
12 ops.
Sell Volume
24Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,305 of 25,804 companies
37.8
score / 100
Value38
Quality38
FCF yld11%
Earn yld-0.3%
EV/EBITDA53.5x
ROE1.9%
Gross mgn6.6%
Net mgn-0.2%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations64 total
25 of 64 declarations
About 화일약품
화일약품 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the manufacturing of pharmaceutical products and healthcare solutions.